Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial quorum sensing (QS) receptors are specialized proteins that detect signaling molecules called autoinducers, allowing bacteria to monitor their population density and coordinate group behaviors (Zhao et al., 2020). In poultry and swine pathogens such as Salmonella enterica, Campylobacter jejuni, and Streptococcus suis, these receptors—including LuxR-type proteins, LuxS/AI-2 systems, and Agr-like systems—regulate the expression of virulence factors and biofilm formation (Ha et al., 2021). By sensing a threshold concentration of signals, these receptors trigger the transition from a commensal or planktonic state to a pathogenic or biofilm-associated state, which is critical for host colonization and disease progression (Zhang et al., 2021). Therapeutic strategies targeting these receptors, known as quorum quenching, aim to disrupt this communication without necessarily killing the bacteria, thereby reducing the selective pressure for antibiotic resistance (Niu et al., 2006). Common inhibitors include phytochemicals like cinnamaldehyde and baicalin, which interfere with signal binding or receptor activation, as well as enzymes like AHL lactonase that degrade the signals themselves (Brackman et al., 2008). These targets are increasingly important in veterinary medicine as alternatives to traditional antibiotics to manage infections like necrotic enteritis and respiratory diseases in livestock.
Quorum quenching via competitive inhibition of autoinducer binding, enzymatic degradation of signaling molecules (quorum quenching enzymes), or inhibition of signal synthesis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial quorum sensing receptors (QS receptors).